Developability of Biopharmaceuticals

-

By accounting for developability in candidate selection, drug developers have the potential to greatly minimize costly attrition and reduce development time significantly. However, this rapidly expanding area is not without its challenges, and key issues surrounding the early implementation of molecular assessments and rational engineering approaches need to be addressed.

Developability of Biopharmaceuticals has been designed to support drug developers in reducing the cost, risk and time of development. Our agenda focuses on the opportunities such as monitoring protein thermostability to ensure optimal conditions for bioprocess and exploring new high throughput screening methods to improve confidence in candidate selection.

Location:
Revere Hotel
USA


Organizer: Hanson Wade

4 Dec 2012

Upcoming Featured Events
1 Next 
analytica10 May 2016
63rd ASMS Conference5 Jun 2016
HPLC 201619 Jun 2016
AACC (American Association for Clinical Chemistry)31 Jul 2016
ASHG 201618 Oct 2016
Neuroscience 201612 Nov 2016


All Upcoming Events
1 2 3 Next 
Cardio-201612 Oct 2016
Nanotech-201612 Oct 2016
Vaccination-201612 Oct 2016
ELRIG Drug Discovery 201613 Oct 2016
ASHG 201618 Oct 2016
BioData World Congress 201626 Oct 2016
Neuroscience 201612 Nov 2016
2016 AAPS13 Nov 2016
MEDICA14 Nov 2016

Advertisement

Advertisement

Advertisement

Advertisement